Abstract

There is a relative scarcity of large-scale population studies investigating the relationship between the insulin resistance index of homeostasis model assessment (HOMA-IR) and vascular damage. Therefore, we assessed the association between HOMA-IR and vascular damage in adults aged 18 years and older in China. A total of 17,985 research subjects were included. Vascular damage markers and relevant laboratory tests were measured. HOMA-IR was calculated as (fasting insulin * fasting blood glucose)/22.5. Vascular damage included arteriosclerosis (ba-PWV > 1800 cm/s), peripheral artery disease (ABI < 0.9), and microalbuminuria (UACR > 30 mg/g). The relationship between HOMA-IR and vascular damage was analyzed using the RCS. The restricted cubic spline (RCS) analysis suggested that HOMA-IR was nonlinearly associated with arteriosclerosis (P for no-liner < 0.01), peripheral artery disease (P for no-liner < 0.01), and microalbuminuria (P for no-liner < 0.01). Further segmented regression analyses revealed that in study subjects with HOMA-IR < 5, we found that HOMA-IR was associated with an increased OR for arteriosclerosis (OR: 1.36, 95% CI (1.28, 1.45), P < 0.01), peripheral artery disease (OR: 1.33, 95% CI (1.10, 1.60), P < 0.01) and microalbuminuria (OR: 1.59, 95% CI (1.49, 1.70), P < 0.01). HOMA-IR is an independent risk factor for vascular damage, both macrovascular and microvascular. The phenomenon of saturation of HOMA-IR with vascular damage needs further investigation.

Details

Title
Association between insulin resistance and vascular damage in an adult population in China: a cross-sectional study
Author
Ma, Cong 1 ; Cheng, Bokai 2 ; Zhou, Lin 3 ; Cai, Shuang 3 ; Qin, Bangguo 3 ; Sun, Jin 3 ; Li, Man 3 ; Zhang, Shuaishuai 3 ; Chen, Yue 3 ; Bao, Qiligeer 3 ; Zhu, Ping 3 ; Xu, Guogang 1 ; Wang, Shuxia 3 

 Chinese PLA General Hospital and Medical School of Chinese PLA, Beijing, China (GRID:grid.414252.4) (ISNI:0000 0004 1761 8894); The Second Medical Center and National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing, China (GRID:grid.414252.4) (ISNI:0000 0004 1761 8894); The Second Medical Center and National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Department of Health Management, Beijing, China (GRID:grid.414252.4) (ISNI:0000 0004 1761 8894) 
 Chinese PLA General Hospital and Medical School of Chinese PLA, Beijing, China (GRID:grid.414252.4) (ISNI:0000 0004 1761 8894); The Second Medical Center and National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing, China (GRID:grid.414252.4) (ISNI:0000 0004 1761 8894); The Second Medical Center and National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Department of Nephrology, Beijing, China (GRID:grid.414252.4) (ISNI:0000 0004 1761 8894) 
 Chinese PLA General Hospital and Medical School of Chinese PLA, Beijing, China (GRID:grid.414252.4) (ISNI:0000 0004 1761 8894); The Second Medical Center and National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Department of Geriatrics, Beijing, China (GRID:grid.414252.4) (ISNI:0000 0004 1761 8894); The Second Medical Center and National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing, China (GRID:grid.414252.4) (ISNI:0000 0004 1761 8894) 
Pages
18472
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3091023219
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.